Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Alosetron hydrochloride (substance) |
Is a |
False |
Alosetron |
Inferred relationship |
Some |
|
Product containing alosetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alosetron |
Inferred relationship |
Some |
1 |
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alosetron |
Inferred relationship |
Some |
|
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Alosetron |
Inferred relationship |
Some |
1 |
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Alosetron |
Inferred relationship |
Some |
1 |
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Alosetron |
Inferred relationship |
Some |
1 |
Alosetron-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alosetron |
Inferred relationship |
Some |
1 |
Alosetron hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Alosetron |
Inferred relationship |
Some |
|
Alosetron only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alosetron |
Inferred relationship |
Some |
1 |
Alosetron only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Alosetron |
Inferred relationship |
Some |
1 |
Product containing precisely alosetron (as alosetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alosetron |
Inferred relationship |
Some |
1 |
Alosetron (as alosetron hydrochloride) 500 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Alosetron |
Inferred relationship |
Some |
1 |